Notice: This company has been marked as potentially delisted and may not be actively trading. Neovasc (NVCN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Closing Bell: Neovasc Inc down on Tuesday (NVCN)April 15, 2023 | theglobeandmail.comTrading was temporarily halted for "NVCN" at 07:04 PM with a stated reason of "News pending."April 11, 2023 | marketbeat.comClosing Bell: Neovasc Inc up on Monday (NVCN)April 11, 2023 | theglobeandmail.comNeovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateMarch 31, 2023 | finance.yahoo.comNeovasc's (TSE:NVCN) investors will be pleased with their solid 171% return over the last yearMarch 9, 2023 | finance.yahoo.comNeovasc Shareholders Approve Acquisition by Shockwave MedicalMarch 6, 2023 | finance.yahoo.comNeovasc Announces German Reimbursement RenewalFebruary 1, 2023 | finance.yahoo.comMergers and Acquisitions in 2023 Off To A Strong Start (NVCN)Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.January 26, 2023 | marketbeat.comNeovasc (NASDAQ:NVCN) Research Coverage Started at StockNews.comStockNews.com initiated coverage on shares of Neovasc in a report on Tuesday. They set a "sell" rating for the company.January 24, 2023 | marketbeat.comNeovasc (NASDAQ:NVCN) Stock Rating Lowered by Bloom BurtonBloom Burton lowered Neovasc from a "buy" rating to a "hold" rating in a research report on Wednesday.January 20, 2023 | marketbeat.comTrading was temporarily halted for "NVCN" at 07:01 AM with a stated reason of "News pending."January 17, 2023 | marketbeat.comNeovasc (NVCN) is on the Move, Here's Why the Trend Could be SustainableJanuary 11, 2023 | finance.yahoo.comRecent Price Trend in Neovasc (NVCN) is Your Friend, Here's WhyDecember 26, 2022 | finance.yahoo.com3 Medical Instruments Stocks on Recovery Path After Dismal 2022December 21, 2022 | finance.yahoo.comNeovasc Announces Progress on COSIRA-II Clinical TrialNovember 28, 2022 | finance.yahoo.comNeovasc Third Quarter 2022 Earnings: Misses ExpectationsNovember 17, 2022 | finance.yahoo.comNeovasc Announces Third Quarter Financial Results and Provides Corporate UpdateNovember 10, 2022 | finance.yahoo.comNeovasc to Report Third Quarter Financial Results on November 10, 2022October 27, 2022 | finance.yahoo.comNeovasc uses conference to announce positive interim clinical data from Neovasc Reducer use - Proactive Investors USASeptember 30, 2022 | proactiveinvestors.comForm 6-K NEOVASC INC For: Sep 20 - StreetInsider.comSeptember 20, 2022 | streetinsider.comNeovasc puts further development of its Tiara transcatheter treatment on hold - Seeking AlphaSeptember 20, 2022 | seekingalpha.comNeovasc Provides Corporate Update Following Clinical Data Release - GlobeNewswireSeptember 20, 2022 | globenewswire.comNeovasc to Participate in LSI Europe 2022 Emerging MedTech Summit - Yahoo FinanceSeptember 17, 2022 | finance.yahoo.comNeovasc to Participate in LSI Europe 2022 Emerging MedTech Summit - GlobeNewswireSeptember 16, 2022 | globenewswire.comNeovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina - GlobeNewswireSeptember 15, 2022 | globenewswire.comNeovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory AnginaSeptember 15, 2022 | finance.yahoo.comNeovasc Announces Participation at Transcatheter Cardiovascular Therapeutics Conf - Marketscreener.comSeptember 8, 2022 | marketscreener.comScaleFlux Announces Partnership with TD SYNNEX to Increase Market Footprint for Next-generation SSDs - Yahoo FinanceSeptember 8, 2022 | finance.yahoo.com32 Shipping Companies Presenting at Capital Link’s 14th Annual New York Maritime Forum September 21, 2022 in New York City - Yahoo FinanceSeptember 8, 2022 | finance.yahoo.comNeovasc Announces Key Events at TCT 2022 - GlobeNewswireSeptember 8, 2022 | globenewswire.comNeovasc Announces Key Events at TCT 2022September 8, 2022 | finance.yahoo.comNeovasc to Participate in H.C. - GuruFocus.comAugust 30, 2022 | gurufocus.comNeovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference - StreetInsider.comAugust 30, 2022 | streetinsider.comNeovasc to Participate in H.C. Wainwright 24th Annual - GlobeNewswireAugust 30, 2022 | globenewswire.comNeovasc: Q2 Earnings Snapshot - Greenwich TimeAugust 12, 2022 | greenwichtime.comNeovasc Announces Second Quarter Financial Results and Provides Corporate Update - Yahoo FinanceAugust 12, 2022 | finance.yahoo.comNeovasc Announces Second Quart - GuruFocus.comAugust 11, 2022 | gurufocus.comNeovasc Announces Second Quarter Financial Results and Provides Corporate Update - GlobeNewswireAugust 11, 2022 | globenewswire.comNeovasc Announces Second Quarter Financial Results and Provides Corporate UpdateAugust 11, 2022 | finance.yahoo.comAvanos Medical (AVNS) Surpasses Q2 Earnings Estimates - NasdaqAugust 9, 2022 | nasdaq.comAsensus Surgical (ASXC) Reports Q2 Loss, Misses Revenue Estimates - NasdaqAugust 8, 2022 | nasdaq.comConocoPhillips (COP) Beats Earnings & Revenue Estimates in Q2 - NasdaqAugust 4, 2022 | nasdaq.comNeovasc to Report Second Quarter Financial Results on August 11, 2022 - GlobeNewswireJuly 28, 2022 | globenewswire.comNeovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations - GlobeNewswireJuly 26, 2022 | globenewswire.comNeovasc Announcing FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations - Marketscreener.comJuly 26, 2022 | marketscreener.comNeovasc Announces FDA Approval Od Planned COSIRA II Sub-Studies And Single Arm Registry To Allow Inclusio - BenzingaJuly 26, 2022 | benzinga.comForm 6-K NEOVASC INC For: Jul 26 - StreetInsider.comJuly 26, 2022 | streetinsider.comNeovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations - Yahoo FinanceJuly 26, 2022 | finance.yahoo.comTranscatheter Mitral Valve Replacement Market - Global Industry Analysis, Trends, and Forecasts to 2028 - ResearchAndMarkets.com - Business WireJuly 23, 2022 | businesswire.comNeovasc Regains Compliance wit - GuruFocus.comJuly 16, 2022 | gurufocus.com Get Neovasc News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter. Email Address ❗ RSVP please! (Ad)Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day. Just click here and secure your spot! NVCN Media Mentions By Week NVCN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCN News Sentiment▼0.200.57▲Average Medical News Sentiment NVCN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCN Articles This Week▼00▲NVCN Articles Average Week Get Neovasc News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OraSure Technologies News AVITA Medical News Delcath Systems News Pulmonx News AngioDynamics News Anika Therapeutics News Utah Medical Products News Orchestra BioMed News NeuroPace News Profound Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCN) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neovasc Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neovasc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
